Performance of Bordetella pertussis IS481 real-time PCR in a vaccine trial setting

APMIS

Volumn 115, Issue 12, 2007, Pages 1370-1375

  Gullsby, Karolina ^a   Hallander, Hans O ^b   Bondeson, Kåre ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bordetella pertussis; IS481; Real time PCR

Indexed keywords

VACCINE;

ARTICLE; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; DIAGNOSTIC VALUE; DNA EXTRACTION; GENE TARGETING; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECA GENE; SENSITIVITY AND SPECIFICITY; SEROLOGY; VALIDATION PROCESS;

BORDETELLA PERTUSSIS; CLINICAL TRIALS AS TOPIC; DNA PRIMERS; DNA, BACTERIAL; HUMANS; PERTUSSIS VACCINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; WHOOPING COUGH;

EID: 37549054054     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2007.00774.x     Document Type: Article

References (37)

1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005 18 : 326 82.
2. de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000 6 : 348 57.
3. Elomaa A, Advani A, Donnelly D, Antila M, Mertsola J, He Q, et al. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine 2007 25 : 918 26.
4. Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjiian R, Finch E, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999 28 : 1230 7.
5. Van Loo IH, Mooi FR. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology 2002 148 : 2011 8.
6. Cassiday P, Sanden G, Heuvelman K, Mooi F, Bisgard KM, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis 2000 182 : 1402 8.
7. Hallander HO, Advani A, Donnelly D, Gustafsson L, Carlsson RM. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J Clin Microbiol 2005 43 : 2856 65.
8. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998 66 : 670 5.
9. Poynten M, McIntyre PB, Mooi FR, Heuvelman KJ, Gilbert GL. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol Infect 2004 132 : 185 93.
10. van Amersfoorth SC, Schouls LM, van der Heide HG, Advani A, Hallander HO, Bondeson K, et al. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol 2005 43 : 2837 43.
11. Yao SM, Lin YC, Chou CY, Chen YY, Hsiao MJ, Chen HY, et al. Antigenic divergence of Bordetella pertussis isolates in Taiwan. J Clin Microbiol 2005 43 : 5457 61.
12. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005 24 : S25 34.
13. Farrell DJ, McKeon M, Daggard G, Loeffelholz MJ, Thompson CJ, Mukkur TK. Rapid-cycle PCR method to detect Bordetella pertussis that fulfills all consensus recommendations for use of PCR in diagnosis of pertussis. J Clin Microbiol 2000 38 : 4499 502.
14. Fry NK, Tzivra O, Li YT, McNiff A, Doshi N, Maple PA, et al. Laboratory diagnosis of pertussis infections: the role of PCR and serology. J Med Microbiol 2004 53 : 519 25.
15. Kosters K, Riffelmann M, Wirsing von Konig CH. Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. J Med Microbiol 2001 50 : 436 40.
16. Sloan LM, Hopkins MK, Mitchell PS, Vetter EA, Rosenblatt JE, Harmsen WS, et al. Multiplex LightCycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens. J Clin Microbiol 2002 40 : 96 100.
17. Templeton KE, Scheltinga SA, van der Zee A, Diederen BM, van Kruijssen AM, Goossens H, et al. Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J Clin Microbiol 2003 41 : 4121 6.
18. Erlandsson A, Backman A, Tornqvist E, Olcen P. PCR assay or culture for diagnosis of Bordetella pertussis in the routine diagnostic laboratory? J Infect 1997 35 : 221 4.
19. Knorr L, Fox JD, Tilley PA, Ahmed-Bentley J. Evaluation of real-time PCR for diagnosis of Bordetella pertussis infection. BMC Infect Dis 2006 6 : 62.
20. Kosters K, Reischl U, Schmetz J, Riffelmann M, Wirsing von Konig CH. Real-time LightCycler PCR for detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol 2002 40 : 1719 22.
21. Reizenstein E, Johansson B, Mardin L, Abens J, Mollby R, Hallander HO. Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchiseptica. Diagn Microbiol Infect Dis 1993 17 : 185 91.
22. Riffelmann M, Wirsing von Konig CH, Caro V, Guiso N. Nucleic Acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 2005 43 : 4925 9.
23. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, Harris DE, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 2003 35 : 32 40.
24. Cloud JL, Hymas WC, Turlak A, Croft A, Reischl U, Daly JA, et al. Description of a multiplex Bordetella pertussis and Bordetella parapertussis LightCycler PCR assay with inhibition control. Diagn Microbiol Infect Dis 2003 46 : 189 95.
25. Loeffelholz MJ, Thompson CJ, Long KS, Gilchrist MJ. Detection of Bordetella holmesii using Bordetella pertussis IS481 PCR assay. J Clin Microbiol 2000 38 : 467.
26. Muyldermans G, Soetens O, Antoine M, Bruisten S, Vincart B, Doucet-Populaire F, et al. External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J Clin Microbiol 2005 43 : 30 5.
27. Reischl U, Lehn N, Sanden GN, Loeffelholz MJ. Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J Clin Microbiol 2001 39 : 1963 6.
28. Antila M, He Q, de Jong C, Aarts Im Verbakel H, Bruisten S, et al. Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J Med Microbiol 2006 55 : 1043 51.
29. Mazengia E, Silva EA, Peppe JA, Timperi R, George H. Recovery of Bordetella holmesii from patients with pertussis-like symptoms: use of pulsed-field gel electrophoresis to characterize circulating strains. J Clin Microbiol 2000 38 : 2330 3.
30. Yih WK, Silva EA, Ida J, Harrington N, Lett SM, George H. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis 1999 5 : 441 3.
31. Favre D, Viret JF. Nucleotide sequence of the recA gene of Bordetella pertussis. Nucleic Acids Res 1990 18 : 4243.
32. van der Zee A, Agterberg C, Peeters M, Schellekens J, Mooi FR. Polymerase chain reaction assay for pertussis: simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol 1993 31 : 2134 40.
33. Reizenstein E, Lindberg L, Mollby R, Hallander HO. Validation of nested Bordetella PCR in pertussis vaccine trial. J Clin Microbiol 1996 34 : 810 5.
34. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996 334 : 349 55.
35. Diavatopoulos DA, Cummings CA, van der Heide HG, van Gent M, Liew S, Relman DA, et al. Characterization of a highly conserved island in the otherwise divergent Bordetella holmesii and Bordetella pertussis genomes. J Bacteriol 2006 188 : 8385 94.
36. Register KB, Sanden GN. Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis. J Clin Microbiol 2006 44 : 4577 83.
37. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog 2005 1 : e45.